Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

New Technique to Calculate CT-Derived Fractional Flow Reserve: Is It Accurate?

New Technique to Calculate CT Fractional Flow Reserve

This study describes the accuracy of the new computed tomography (CT) technique to calculate fractional flow reserve (FFR).

 

Other CT techniques to measure FFR use allometric scaling and assume coronary microvascular resistance. However, instead of assuming these parameters, this new technique calculates them based on coronary and aorta lumen deformation. The accuracy of this new technique has not been established yet.

 

The study prospectively analyzed 42 patients (78 vessels) undergoing multislice CT (320 detectors) in addition to conventional invasive FFR measurement.

 

Deformation of coronary cross-sectional lumen and aorta acquired over diastole was used to derive CT-FFR. Researchers used a conventional computer and the pertinent software. 

 

The first 12 patients were used to determine CT-FFR optimal cutoff value, which turned out to be identical to the conventional FFR cutoff value (≤0.8). The next 30 patients validated these results.

 

The first cohort showed that CT-FFR optimal cutoff value was 0.8, with 67% sensitivity and 91% specificity.

 

In the validation cohort, CT-FFR was successfully measured in 56 of the 58 analyzed vessels (97%). Compared to anatomical CT images alone, CT-FFR ≤0.8 showed higher specificity (87% vs. 74%) and positive predictive value (74% vs. 60%) with comparable sensitivity (78% vs. 79%) and negative predictive value (89% vs. 88%).

 

Mean analysis time of CF-FFR per patient was 27.07 ± 7.54 min.

 

Conclusion

This new technique to measure CT-FFR is feasible and extremely easy to replicate with a conventional FFR cutoff value of 0.8. It requires a short processing time and can be done in a conventional computer.

 

Editorial Comment

Computed tomography FFR is a less invasive diagnostic tool, it is safe, and in some countries, less expensive than conventional coronary angiography. On the other hand, it adds radiation and contrast and does not solve the problem with ad hoc PCI, which makes it useless in case of patients at high risk of heart disease.

 

Original Title: Noninvasive CT-Derived FFR Based on Structural and Fluid Analysis- A Comparison with Invasive FFR for Detection of Functionally Significant Stenosis.

Reference: Ko BS et al. J Am Coll Cardiol Img. 2016. Online before print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...